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A B S T R A C T
Mucoepidermoid carcinoma (MEC) accounts for approximately 30% of malignant salivary gland tumors and approx-
imately 30% occur in minor salivary glands. The palate is the most frequent localization for those arising in minor
glands. A 33-year-old male patient with MEC of the hard palate was treated as an acute odontogenic infection, which
was not cured after tooth endodontic treatments, repeated incisions and antibiotics. On the hard palate ovoid, a hard
painless mass, which had not extended over the middle palatal line, was observed. Partial maxillectomy was performed.
A review of the literature was performed in order to provide a coherent overview on the differential diagnosis of palatal
lesions. To the best of authors’ knowledge, this is the first report in English literature describing palatal MEC mis-
diagnosed and treated as odontogenic infection. Considering the extensive list of MEC’s differential diagnoses on the
hard palate, acute odontogenic infection can now be added to that list.
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Introduction
In 1945, Stewart et al.1 published the first large series
of mucoepidermoid carcinomas (MECs) and suggested
the term MEC. They divided these tumors into benign
and malignant varieties, however, due to the appearance
of metastases, Foote and Franzell considered all MECs
malignant2, and it is the most common malignant tumor
of minor salivary glands (MSGT) in the oral cavity3–7.
The incidence of salivary gland tumors increased with
age8. However, it is important to realize that the relative
incidence of malignant tumors increases, as the size of
the glands in which they develop decrease9. MEC ac-
counts for up to 47% of all malignant salivary gland
tumors10,11 and 21.1% of benign and malignant salivary
gland tumors with 30% appearing in the minor salivary
glands12. In studies after 1990, MEC represented 45%, a
twofold increase in comparison with studies before 1990
(an average of 27% of all malignant salivary tumors)13.
These findings are inconsistent and not sufficient to sug-
gest a geographic related appearance14. Reviewing the
English-language literature, Buchner et al.15 concluded
that it was very difficult to make a valid comparison be-
tween intra-oral minor salivary gland tumors because
many reports were based on outdated classification, the
small number of some cases, limited list of tumors, and
new entities are not included. Pires et al.16 concluded
that reports from different populations using the same
diagnostic criteria are essential to compare and estimate
true racial and geographic variations in MSGT. The pal-
ate is the most frequent localization for those arising in
the minor glands8. Some authors4–7,17–21 found a higher
incidence of palatal involvement by salivary gland tu-
mors, including MEC. Wang et al.22 found that palate was
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the most commonly affected site among intraoral minor
salivary gland tumors in a Chinese population.
In adults, MEC is most common in the fourth to sixth
decades with no established gender predominance23. Mi-
croscopically, MEC is composed of mucous cells, epider-
moid cells and intermediate cells1.
Low-grade carcinomas appear as painless, slowly en-
larging ovoid masses, which are greater than 2–3 cm in
diameter and rarely larger than 4 cm, may produce
metastases and have a 5-year determinate cure rate of
approximately 90% with a recurrence rate of 6%24. Onco-
cytic MEC (OMEC) has been rarely reported with previ-
ous cases suggesting they are largely cystic low-grade
neoplasms with a favorable prognosis. The differential
diagnosis of OMEC includes numerous oncocytic/»on-
cocytoid« neoplasms. Although recent evidence suggests
that, unlike in OMEC, p63 is a reliable marker in the di-
agnosis of conventional MEC, OMEC behaved as a low-
-grade tumor, and is diffusely positive fot p63, which may
aid in its differential diagnosis25. High-grade MECs pres-
ent as painful, rapidly enlarging masses that tend to be
firmer and less moveable, with a 5-year determinate cure
rate of 27%. These are associated with a high recurrence
rate (78%) and metastases26. Okami et al.27 found a meta-
static MEC in the lung 43 years after the initial treat-
ment for the primary tumor.
Intraosseous salivary gland tumors are most com-
monly MECs, usually asymptomatic,
three-fold more common in the mandible then in the
maxilla in the region of the third molar and occur twice
as often in women. It is believed that these tumors arise
from the odontogenic cysts or salivary glands entrapped
during embryological development28.
Differential diagnosis on the hard palate includes all
benign and malignant tumors of the hard palate, mostly
pleomorphic adenoma, polymorphous low-grade adeno-
carcinoma, adenoid cystic carcinoma and squamous cell
carcinoma. Chronic sialadenitis or mucocoele, which is
histologically similar, could be misdiagnosed as a low-
-grade MEC or necrotizing sialometaplasia. Odontogenic
cysts, lymphoma, plasmacytoma, Langerhans cell histio-
cytosis or metastatic carcinoma could also be included as
well as a rare papillary oncocytic cystadenoma29.
To the best of authors’ knowledge, this is the first re-
port in English literature describing palatal MEC mis-
diagnosed and treated as odontogenic infection.
Case Report
A 33-year-old male patient visited the dentist com-
plaining of upper first molar toothache. On the left side
of the hard palate ovoid, a hard painless mass, which had
not extended over the middle palatal line, was observed.
The dentist, who began the initial endodontic treatment
and filled root canals, using iodoform paste (Vitapex) for
one week, did not indicate an incision. After 7 days, the
dentist performed the palatal incision, no puss was de-
tected and no improvement occurred.
One month later, the patient was referred to the out-
patient oral surgeon who performed a re-incision. Seven
days later, some improvement had occurred. The oral
surgeon advised the endodontic treatment to be contin-
ued. Three months later, the patient visited his dentist
with the same palatal ovoid mass; however, the patient
experienced no toothache. The patient was subsequently
admitted to our Department.
An ortopantomograph revealed semiovoid transpar-
ency of the left maxillary alveolar process above the teeth
roots that lifted the hard palate and floor of the maxillary
sinus (Figure 1). An axial CT scan showed a pathological
process of the hard palate (diameter, 25 mm) with cystic
bone transformation and a small bone infraction (Figure
2). Coronal CT showed the submucous mass near the al-
veolar ridge and thickening of the Schneider’s mem-
brane of the left maxillary sinus without bone destruc-
tion (Figure 3). A presumptive diagnosis was pleomorphic
adenoma. A cytological diagnosis considered a low-grade
MEC or cytologically similar mucocoele. The histopatho-
logical diagnosis of a biopsy specimen was MEC, grade 1.
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Fig. 1. An ortopantomograph reveals semi-ovoid transparency of
the left maxillary process above the teeth roots, which lifts the
hard palate and floor of the maxillary sinus.
Fig. 2. Axial CT scan shows the pathological process of a hard
palate (25 mm in diameter) with a cystic bone transformation
and a small bone infraction.
A partial maxillectomy was subsequently performed. Fig-
ure 4 shows the tumor specimen. The palatal plate was
placed immediately following surgery.
Histopathological examination of the excised portion
of the hard palate revealed an invagination in the central
portion of the bone, occupied by a soft, partially cystic
node measuring 2 cm in diameter. The tumor was com-
posed of multiple cystic spaces lined by well-differenti-
ated mucinous cells, intermixed with intercalated and oc-
casionally squamous epithelial cells. One of the larger
cystic spaces contained a papillary structure lined by
multilayered squamous epithelium with scattered mu-
cinous cells. Pools of mucinous material with occasional
multinucleated foreign-body giant cells were present wi-
thin the fibrous stroma. The tumor tissue was inva-
ginated into the underlying bone with pushing borders
showing minute evidence of infiltration. Adjacent sali-
vary glands were normal as well as surgical margins (Fig-
ure 5). Figure 6 shows the post surgical defect, 5 years
following treatment, with no signs of recurrence.
Discussion and Differential Diagnosis
of Palatal Lesions
In our case, the initial diagnosis and long term unsuc-
cessful treatment clearly indicates that the initial diag-
nosis and the subsequent treatment administered should
have been revised. Minor salivary gland tumors are, in
fact, uncommon tumors of the oral cavity. They are found
mostly on the hard palate, as in our case, but also on the
tongue, buccal mucosa, soft palate and other sites30.
The extensive list of differential diagnoses possibili-
ties can result in confusion, as follows.
Pleomorphic adenoma
Pleomorphic adenoma is the most common benign tu-
mor and MEC is the most common malignant tumor of
minor salivary glands in the oral cavity3. The pleomor-
phic adenoma, or benign mixed tumor, is the most com-
mon salivary gland tumor. The mean age of occurrence is
45 years, with a male-to-female ratio of 3:2. In minor
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Fig. 3. Coronal CT shows the submucous mass near the alveolar
ridge and thickening of the Schneider’s membrane of the left
maxillary sinus without bone destruction.
Fig. 4. Tumor specimen with a suture in the center of a palatal
mass, at the biopsy site.
Fig. 5. Histopathological examination of the excised portion of
hard palate reveals an invagination in the central portion of the
bone, occupied by a soft, partially cystic node measuring 2 cm in
diameter. The tumor is composed of multiple cystic spaces lined
by well-differentiated mucinous cells, intermixed with intercala-
ted and occasionally squamous epithelial cells (hematoxylin-eo-
sin stain, original magnification x 200).
Fig. 6. Postsurgical defect on the left side of the hard palate, with
no signs of recurrence, 5 years after surgery.
glands, the most common site is the palate where it usu-
ally presents as a slow-growing, painless mass. There is a
small risk of recurrence, as well as a small (5%) risk of
malignant transformation to a carcinoma-ex pleomor-
phic adenoma12,15,17. Matsubayashi and Yoshihara31 sug-
gested that carcinoma ex pleomorphic adenoma acquired
the particular biological behavior in contrast to the other
salivary neoplasms in the long-standing process while
pleomorphic adenoma undergoes malignant transforma-
tion.
Myoepithelioma
Myoepithelioma, in most studies probably included
within the group of pleomorphic adenoma, is defined as a
tumor composed almost exclusively of myoepithelial cells32.
Buchner et al.15 reported five intraoral lesions, two of
them located in the palate. The criteria to distinguish
myoepithelioma from pleomorphic adenoma with a pre-
dominance of myoepithelial cells are largely subjective33.
Myoepithelial carcinoma (MC), also known as malig-
nant myoepithelioma, is a rare malignant salivary gland
tumor with a predilection for the parotid gland. Yang et
al.34 described seven cases of MC of intraoral minor sali-
vary glands and found three cases arose in the hard pala-
te. It is a low-grade malignant tumor with little propen-
sity for regional or distant metastasis and low recurrence.
Wide local excision is the treatment of choice. MC with
predominantly clear cell morphology is rare35.
Warthin’s tumor
The papillary cystadenoma lymphomatosum or War-
thin’s tumor almost exclusively affects the parotid gland,
especially the tail. The peak incidence occurs during the
sixth decade of life, with a male-to-female ratio of 7:1.
This lesion presents itself as a slow-growing, soft pain-
less mass28,36. Ciapasco et al.37 presented Warthin’s tu-
mor of the palate. They presumed that the lymphoid tis-
sue is reactive and a direct origin from the ductal epithe-
lium with secondary lymphocytic infiltration is more
likely to occur.
Basal cell adenoma
The basal cell adenoma is an uncommon solitary le-
sion composed of one cell type, affecting predominantly
the upper lip minor glands (canalicular adenoma) and
the parotid gland (basal cell adenoma). In a few studies
canalicular adenoma involved the palate12,15.
Ductal papilloma
Ductal papillomas (benign papillary lesions) include
intraductal papilloma, inverted ductal papilloma, and
sialadenoma papilliferum29. The palate is the most com-
mon location of sialadenoma papilliferum, although ca-
ses of other ductal papillomas involving the palate have
been presented15,38. The most important lesion to distin-
guish from inverted ductal papilloma is MEC, because
they both have epidermoid and mucous cells. Unlike in-
verted ductal papillomas, MECs are multicystic or multi-
nodular and infiltrate surrounding tissue39.
Neurilemmoma
Neurilemmoma (schwannoma, neurolemoma, neuri-
noma, perineural fibroblastoma, peripheral glioma, and
peripheral nerve sheat tumor) is a common, histolo-
gically distinctive, benign, usually encapsulated, periph-
eral nerve tumor originated from Schwann cells that
cover myelinated nerve fibers. Intraoral development is
uncommon (only 1%). The palate is the second frequent
intraoral location40–42.
Lipoma
Lipomas and lipoma variants are relatively uncom-
mon in the oral region. Overall incidence in the oral cav-
ity is between 1% and 4.4% of all benign oral lesions43.
Furlong et al.44 reported six palatal out of 78 intraoral
lipomas. Most patients presented with an asymptomatic,
circumscribed mass; the duration of the tumors prior to
excision ranged 6 weeks to 15 years. Fanburg-Smith et
al.45 reported one palatal out of 14 intraoral liposarcomas
which are rare in the oral and salivary gland region.
They concluded that local excision and careful follow-up,
without adjuvant therapy, appears to be the best treat-
ment of salivary gland region liposarcoma.
Polymorphous low-grade adenocarcinoma
The polymorphous low-grade adenocarcinoma is, fol-
lowing MEC, the second most common intraoral salivary
gland malignancy. It was first described in 1983 and prior
to this, was probably misdiagnosed as an adenoid cystic
carcinoma. The most common site is the junction of the
hard and soft palate. The male-to-female ratio is 3:1,
with a mean age of 56 years. This tumor presents as a
slow-growing, asymptomatic mass that may be ulcera-
ted28,29,36.
Adenoid cystic carcinoma
The adenoid cystic carcinoma, the third most com-
mon type of the intraoral salivary gland malignancies, af-
fects older individuals, where the mean age of occurrence
is 53 years with a male-to-female ratio of 3:2. Fifty per-
cent of these tumors occur in the parotid gland, whereas
the other 50% occur in the minor gland of the palate.
These present as slow-growing, ulcerated masses, with
an associated chronic dull pain29.
Hybrid tumors are very rare salivary gland lesions
composed of two or more different tumoral entities in a
single neoplasm. In most cases, adenoid cystic carcinoma
has been the predominant component in these lesions.
Ruiz-Godoy et al.46 described two patients with hybrid
tumors located in the palate, one involved adenoid cystic
carcinoma and MEC.
Clear cells tumor
Clear cells tumors are observed in several malignant
salivary gland tumors including MEC33. Occasionally,
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mucin material from structural MEC’s cysts leak into
the surrounding stroma, resulting in an inflammatory
reaction and a nonrepresentative biopsy may mislead the
physician to a diagnosis of chronic sialadenitis, which is
painful. On some occasions, the inflammatory response
may lead to extensive fibrosis, so-called sclerosing MEC47.
Information concerning calcifications in clear cell MEC
of the salivary gland is very scarce. Yang and Chen48 con-
cluded that clear cell MEC should be considered in the
differential diagnosis of salivary gland tumors with calci-
fication.
Acinic cell carcinoma
Acinic cell carcinoma (ACC) is an infrequent malig-
nant salivary gland tumor. Approximately 16% of all
ACCs occur in the mouth; it accounts for 6% of all pri-
mary salivary gland neoplasms and 17% of all primary
malignant salivary gland tumors. Omlie and Coutlas49
found 28.6% out of 21 ACC’s cases in the palate. In gen-
eral, intraoral ACCs are more common in the buccal mu-
cosa, upper lip and palate; more frequent in women; usu-
ally asymptomatic and slow-growing, and treated with
local excision; much less aggressive in the minor salivary
glands, and patients rarely die of disease, and tumors sel-
dom metastasize. Triantafillidou et al.50 concluded that
ACCs are characterized by an indolent clinical course
with the potential for both local recurrence and distant
metastases. Hystologically, microcystic, papillary cystic,
follicular and solid, and combinations of these types
characterize the lesions.
Cystadenoma
Papillary oncocytic cystadenoma of palatal minor sali-
vary glands is a very rare lesion but is important in the
differential diagnosis on a palate. Cystadenomas of sali-
vary gland origin are benign, well-circumscribed or en-
capsulated, multicystic neoplasms that can exhibit in-
tracystic papillations. The relative rarity of such lesions
is reflected by their exclusion from many principal surgi-
cal pathology texts and major review articles51. Cysta-
denoma of the minor salivary gland occurs very rarely
and presents as a painless mass beneath the mucosa of
the hard palate, cheek or posterior tongue. Occurrence of
oncocytic carcinoma (or malignant oncocytoma) arising
from minor salivary glands of the sinonasal tract is an
unusual event52. As oncocytic metaplasia and oncocyto-
mas are most often observed in older individuals, the
oncocyte was previously regarded as a »functional ex-
haustion« of a normal cell. Most reported cases were
treated by simple excision without recurrence. Recur-
rences are attributable to incomplete excision or due to
the mistaken diagnosis of a low-grade cystadenocar-
cinoma51,53.
Angiosarcoma
Angiosarcomas of the oral and salivary gland region
are extremely rare, often with relatively good outcome.
Fanburg-Smith et al.54 reported 22 primary and 7 sec-
ondary angiosarcomas; one palatal out of 18 intraoral
angiosarcomas. Symptoms included a mass with recent
enlargement and bleeding. Histologically all tumors were
vasoformative (commonly spindled); most of them had
solid rather then distinctive papillary areas; almost one
third of oral and salivary gland angiosarcomas are the
rare epitheloid angiosarcoma variant.
Metastatic tumors
Metastatic disease of the oral cavity is uncommon,
representing 1% of all oral malignancies, however, the
mandibular molar and premolar regions are the most fre-
quently (61%) affected sites55. The most common pri-
mary sites are lungs, prostate, kidney, bone, adrenal
glands and breast, colorectal, genital tract and thyroid in
females. Lim et al.56 found the liver being the most com-
mon primary site. The lung was the most common pri-
mary site for the jawbone metastases, whereas the liver
was for those of oral soft tissue. They concluded this dis-
crepancy might be caused by a relatively high incidence
of hepatocellular carcinoma in Koreans. They reported
one palatal out of 18 oral soft tissue metastases. Van der
Waal et al.57 reported three palatal out of 24 intraoral
metastatic tumors. Primary sites were kidney (clear cell
carcinoma), colon and oesophagus (both adenocarcino-
ma). The majority of these malignancies are poorly de-
fined radiographically with occasional mixed or radio-
paque lesions55.
Lymphoma
Lymphoma and plasmacytoma of the jaws usually oc-
curs in older adult patients and presents as an asymp-
tomatic, ill-defined area of radiolucency. Langerhans cell
hystiocytosis and squamous odontogenic tumor can pro-
duce bony destruction that mimics focal periodontal dis-
ease. The former condition is often associated with radio-
graphic appearance of »float teeth«; the latter often
results in a wedge-shaped radiolucent defect between the
teeth58. Lymphomas of the palate are rare lesions and
those arising from the mucosa-associated lymphoid tis-
sue (MALT) located in the hard palate were first reported
in 200659.
Intraosseous tumors
Primary intraosseous squamous cell carcinoma is mo-
re common in older adult men than MEC, but both can
result from malignant transformation of pre-existing
dentigerous cysts, periapical cysts, odontogenic kerato-
cysts and residual cysts60,61.
Primary central mucoepidermoid carcinoma (CMEC)
is an uncommon lesion that was first described by Leep
in 193962, with a high predilection for a mandibular loca-
tion with an average age of onset in the mid-30s28. It rep-
resents less than 1% of all salivary gland MECs. The fact
that 30–50% of CMEC cases are associated with impacted
teeth has even led some authors to classify CMEC as
odontogenic28. Occasionally, it is difficult to distinguish
between central and peripheral salivary gland origin.
The criteria for diagnosis of intraosseous MEC are the
following: presence of intact cortical plate; radiographic
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evidence of bone destruction; histologic conformation;
positive mucin staining; absence of primary lesion in the
salivary gland and exclusion of an odontogenic tumor63.
Biswas and Crank64 presented findings regarding the
relative distribution of various conditions causing maxil-
lary swelling and found 20.8% of palatal bulge. Clinically
they found 5 infected/carious teeth and 10.4% dental and
dentigerous cysts among 48 patients and 45.4% among
11 non-neoplastic lesions.
It has been suggested that residual odontogenic cysts
are the most common form of odontogenic cysts to un-
dergo carcinomatous transformation, which is a rare
complication61. It is also not unusual to misdiagnose the
non-ulcerative form of necrotizing sialometaplasia as
squamous cell carcinoma or MEC. Patients with intra-
oral MEC had a reduced survival expectation if they were
of a male gender, with regional metastasis, high grade of
malignancy, strong expression of PCNA and weak expres-
sion of c-erbB-2, which plays an important role in the de-
velopment, differentiation and mitogenic signalization in
normal cells65.
Conclusion
Considering the extensive list of differential diagno-
ses on the hard palate, unfortunately, acute odontogenic
infection, as we previously reported66, can now be added
to that extensive list. However, the most important fac-
tors for presumptive diagnosis of tumorous lesions on
the hard palate are time of presence, relation to the mid-
dle palatal line, presence of pain and the nature of bone
destruction.
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MUKOEPIDERMOIDNI KARCINOM POGRE[NO DIJAGNOSTICIRAN KAO ODONTOGENA UPALA.
PREGLED DIFERENCIJALNE DIJAGNOZE NEP^ANIH LEZIJA
S A @ E T A K
Mucoepidermoidni carcinom (MEC) ~in,i oko 30%malignih tumora `lijezda slinovnica i otprilike isto toliko ih nasta-
je u malim `lijezdama slinovnicama. Nepce je naj~e{}a lokalizacija onih koji nastaju u malim `lijezdama slinovnicama.
Bolesnik star 33 godine s nep~anim MEC-om neuspje{no je lije~en kao akutna odontogena upala, koja nije reagirala na
endodontsko lije~enje zuba, vi{ekratne incizije i antibiotike. Na tvrdom nepcu postojala je polukuglasta, tvrda, bezbolna
tvorba koja nije prelazila sredi{nju liniju.U~injena je djelomi~na maksilektomija. Temeljem pregleda literature prikazu-
jemo diferencijalnu dijagnozu nep~anih lezija. Koliko je autorima poznato ovo je prvi prikaz nep~anoga MEC-a pog-
re{no dijagnosticiranoga i lije~enoga kao odontogena upala. S obzirom da diferencijalno dijagnosti~ki postoje brojne
promjene na nepcu, sada u diferencijalnu dijagnozu MEC-a mo`emo pribrojiti i akutnu odontogenu upalu.
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